New Delhi, July 17: Gaudium IVF and Women Health Limited, India’s first publicly listed IVF chain, kicked off its first milestone in the Company’s planned 19-centre expansion, as outlined in the growth roadmap shared with investors during its IPO. The launch reinforces the Company’s commitment to making high quality, technology driven ferƟlity care more accessible to aspiring parents through a standardised clinical and laboratory model that combines AI powered innovaƟon with the highest standards of clinical excellence, paƟent safety and ethical care.
Strategically located in South Delhi, the new centre offers comprehensive ferƟlity care under one roof, combining experienced ferƟlity specialists, advanced reproducƟve medicine and Gaudium IVF’s standardised clinical protocols. At the heart of the new centre is the Gaudium Signature Lab, the Company’s proprietary laboratory framework that integrates advanced embryology, AI-powered technologies and internaƟonally benchmarked quality standards to create an opƟmal environment for embryo development. As Gaudium IVF expands its network, the Signature Lab model will be replicated across every new centre, ensuring paƟents experience the same high standards of precision, safety and clinical excellence, irrespecƟve of locaƟon.
The centre also brings together Gaudium IVF’s AI-powered embryology ecosystem, including SiD for advanced sperm assessment and ERICA (Embryo Ranking Intelligent ClassificaƟon Assistant) for embryo evaluaƟon. By complemenƟng the experƟse of embryologists with data-driven insights, these technologies enhance precision, consistency and confidence throughout the IVF journey.
Built on a 17-year legacy of innovaƟon and paƟent-centric care, Gaudium IVF has established itself as one of India’s trusted ferƟlity care providers. Its commitment to laboratory excellence has been recognised internaƟonally with the European Quality Award from ESQR, Spain, reinforcing the high standards that underpin the Company’s clinical outcomes, including in complex inferƟlity and recurrent IVF failure cases.
CommenƟng on the launch, Dr. Manika Khanna, Chairperson and Managing Director, Gaudium IVF, said:
“FerƟlity care is one of the most specialised fields of medicine, where science, clinical experƟse and ethical pracƟces come together to help couples realise their dream of parenthood. At Gaudium IVF, we believe every paƟent deserves care that is not only clinically advanced but also transparent, compassionate and centred around their individual needs.
The launch of our South Extension centre reflects our commitment to making world-class ferƟlity care more accessible without compromising on the standards that have guided us for the past 17 years. As we expand our network, our focus remains on building centres that combine scienƟfic excellence, AI-powered innovaƟon and globally benchmarked laboratory standards with a paƟent-first approach. The Gaudium Signature Lab reflects this philosophy by bringing together qualified embryologists, technologically advanced laboratory, ethical pracƟces and evidence-based care to support informed clinical decisions and provide paƟents with the highest standards of ferƟlity care. These principles will conƟnue to guide every step of our growth journey.”
The launch comes at a Ɵme when demand for specialised ferƟlity care conƟnues to grow across India, driven by delayed parenthood, changing lifestyles and increasing awareness of assisted reproducƟve technologies. Through its planned network expansion, Gaudium IVF aims to replicate its Signature Lab model across new centres, combining advanced reproducƟve medicine, AI-powered embryology and standardised clinical protocols to deliver consistent, high-quality ferƟlity care at scale and reinforce its leadership in India’s rapidly evolving ferƟlity care sector.